TP53 and central nervous system cancer: In addition, given the complexity of the p53 pathophysiological network in apoptosis, senescence, growth arrest and the high mutation rate in GBM, approaches of gene therapy that involve increasing PUMA expression may be an improved approach to reverse TMZ resistance in glioma cells.